These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials. Pénzváltó Z; Chen JQ; Tepper CG; Davis RR; Silvestrini MT; Umeh-Garcia M; Sweeney C; Borowsky AD J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):149-162. PubMed ID: 30810966 [TBL] [Abstract][Full Text] [Related]
3. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658 [TBL] [Abstract][Full Text] [Related]
4. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Alikhani N; Ferguson RD; Novosyadlyy R; Gallagher EJ; Scheinman EJ; Yakar S; LeRoith D Oncogene; 2013 Feb; 32(8):961-7. PubMed ID: 22469977 [TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration. Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
9. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493 [TBL] [Abstract][Full Text] [Related]
10. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Varticovski L; Hollingshead MG; Robles AI; Wu X; Cherry J; Munroe DJ; Lukes L; Anver MR; Carter JP; Borgel SD; Stotler H; Bonomi CA; Nunez NP; Hursting SD; Qiao W; Deng CX; Green JE; Hunter KW; Merlino G; Steeg PS; Wakefield LM; Barrett JC Clin Cancer Res; 2007 Apr; 13(7):2168-77. PubMed ID: 17404101 [TBL] [Abstract][Full Text] [Related]
11. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer. Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571 [TBL] [Abstract][Full Text] [Related]
12. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953 [TBL] [Abstract][Full Text] [Related]
13. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. White DE; Cardiff RD; Dedhar S; Muller WJ Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830 [TBL] [Abstract][Full Text] [Related]
14. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177 [TBL] [Abstract][Full Text] [Related]
15. Studies of mammary carcinoma metastasis in a mouse model system. I: Derivation and characterization of cells with different metastatic properties during tumour progression in vivo. Barnett SC; Eccles SA Clin Exp Metastasis; 1984; 2(1):15-36. PubMed ID: 6085722 [TBL] [Abstract][Full Text] [Related]
16. Proteotypic classification of spontaneous and transgenic mammary neoplasms. Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849 [TBL] [Abstract][Full Text] [Related]
18. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670 [TBL] [Abstract][Full Text] [Related]
19. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines. Davies BR; Barraclough R; Rudland PS Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111 [TBL] [Abstract][Full Text] [Related]
20. Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Cunningham HD; Shannon LA; Calloway PA; Fassold BC; Dunwiddie I; Vielhauer G; Zhang M; Vines CM Transl Oncol; 2010 Dec; 3(6):354-61. PubMed ID: 21151474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]